Home/Filings/4/0000950170-24-015548
4//SEC Filing

Davis Andrew 4

Accession 0000950170-24-015548

CIK 0001446847other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 8:42 PM ET

Size

9.6 KB

Accession

0000950170-24-015548

Insider Transaction Report

Form 4
Period: 2024-02-12
Davis Andrew
SVP, Chief Business Officer
Transactions
  • Sale

    Class A Common Stock

    2024-02-12$15.24/sh9,846$150,053208,324 total
  • Award

    Class A Common Stock

    2024-02-12+65,312273,636 total
  • Award

    Performance-based Restricted Stock Unit

    2024-02-12+32,65632,656 total
    Exp: 2027-02-28Class A Common Stock (32,656 underlying)
Footnotes (5)
  • [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The reporting person acquired 796 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2023.
  • [F4]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F5]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Documents

1 file

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001932525

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:42 PM ET
Size
9.6 KB